Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
MPN
COVID-19
Events

Playback speed

10 seconds

ASCO® GU 2024 Insights: "HER2 and PD-L1 Immunohistochemistry Expression, and HER2 Genomic Alterations - Associations and Clinical Outcomes for Advanced Bladder Cancer"

By Insights from 2024 ASCO® GU Annual Meeting FEATURING David Aggen

112 views

February 20, 2024

Comments 0

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Genitourinary

Multidisciplinary Approaches for Muscle Invasive Bladder Cancer

Memorial Sloan Kettering Cancer Center

B. Bochner

201 views

Clinical Perspectives on Managing Hereditary Kidney Cancer

Memorial Sloan Kettering Cancer Center

J. Coleman

53 views

ASCO® GU 2024 Insights: "HER2 and PD-L1 Immunohistochemistry Express…

Insights from 2024 ASCO® GU Annual Meeting

D. Aggen

112 views

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of P…

Insights from 2023 ESMO Annual Meeting

M. Voss

132 views

The Best of GU Radiation Oncology

OncoAlert

S. McBride

278 views

Theranostics and the Changing Face of Prostate Cancer

University of Colorado Cancer Center

M. Morris

248 views

ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder …

ASCO 2022 Conference Coverage

G. Iyer

131 views

Lecture Summary - Results of Phase II Clinical Trial of Cabozantinib…

Memorial Sloan Kettering Cancer Center

C. Lee

19 views

Results of Phase II Clinical Trial of Cabozantinib + Nivolumab for A…

Memorial Sloan Kettering Cancer Center

C. Lee

77 views

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTUC: F…

ASCO Genitourinary Cancers Symposium

W. Yip

92 views

ASCO 2021 Update on mCRPC: VISION Trial Data on Lutetium-177-PSMA-617

ecancer

M. Morris

39 views

04:46

Memorial Sloan Kettering Cancer Center

2020 Update on mRCC: Lenvatinib + Pembro After CPIs: Is There a Bene…

Feat. C. Lee